Here's What Higher for Longer Means for the Stock Market 

Stocks are still trading near record levels, but some investors say further gains may be more difficult to come by.

Certain Biotech Investors Get an Early Look at Results. Is That Fair? 

Private investments in public equities, or PIPEs, are all the rage in biotech, but some investors resent the sharing of nonpublic information.

CVC Looks to Raise at Least $1.3 Billion in Amsterdam IPO 

The global buyout firm is making a second attempt to go public in less than six months.

Goldman Sachs Prepares to Release Earnings After Rival Banks Set Sullen Tone 

The investment bank follows a string of lackluster results from U.S. banks last week.

BNP Paribas Buys Fosun's Stake in Ageas 

BNP Paribas is buying Fosun's 9% shareholding in Belgium insurer Ageas for roughly $777 million.

Franklin Templeton Turns Toward Private Investing as Mutual-Fund Business Shrinks 

After a string of acquisitions, the firm now manages more than $260 billion in alternative assets like private credit.

Will Banks Finally Have to Pay You More for Your Savings? 

Deposit costs are still a moving target, even for the biggest banks.

Two Brothers, a Big Biotech Bet and an $8 Billion Payout 

Investors in a hedge fund from Baker Bros. Advisors recently received one of the largest windfalls ever following Pfizer's purchase of Seagen.

Supreme Court Finds Macquarie Infrastructure Not Liable for Omitting Risks 

Investors can't hold the infrastructure business liable for securities fraud for failing to disclose how a U.N. regulation would affect its commodities storage business.

High Rates Have Been a Profit Machine for Banks. Not Anymore. 

America's biggest bank warned that it is starting to pay more on customer deposits.

(END) Dow Jones Newswires

04-15-24 0715ET